Skip to main content

Neues zu seltenen rheumatologischen Erkrankungen in der Schwangerschaft

New aspects of rare rheumatic diseases during pregnancy

Zusammenfassung

Für einige seltenere rheumatische Erkrankungen ist die Datenlage zu Fertilität und Schwangerschaft immer noch gering. Dieser Beitrag versucht die bis dato bekannten Daten wiederzugeben und auch einige Therapieempfehlungen daraus abzuleiten und zu ergänzen. Eine stabile Krankheitseinstellung vor der Schwangerschaft reduziert das Komplikationsrisiko für Mutter und Kind drastisch, daher ist eine entsprechende Therapieanpassung rechtzeitig in Absprache mit Patienten und Gynäkologen wichtig.

Abstract

For some rare rheumatic diseases the data situation on fertility and pregnancy is still scant. This article attempts to present the data known so far and to derive and supplement some treatment recommendations from the data. A stable disease situation before the pregnancy drastically reduces the risk of complications for mother and child; therefore, an appropriate and timely adjustment of treatment in consultation with patients and gynecologists is important.

This is a preview of subscription content, access via your institution.

Literatur

  1. 1.

    Munira S, Christopher-Stine L (2020) Pregnancy in myositis and scleroderma. Best Pract Res Clin Obstet Gynaecol 64:59–67

    Article  PubMed  Google Scholar 

  2. 2.

    Ross C, D’Souza R, Pagnoux C (2020) Pregnancy outcomes in systemic vasculitides. Curr Rheumatol Rep 22(10):63

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Nguyen V, Wuebbolt D, Pagnoux C, D’Souza R (2021) Pregnancy outcomes in women with primary systemic vasculitis: a retrospective study. J Matern Fetal Neonatal Med 34(17):2771–2777. https://doi.org/10.1080/14767058.2019.1671329

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Tanacan A, Unal C, Yucesoy HM, Duru SA, Beksac MS (2019) Management and evaluation of pregnant women with Takayasu arteritis. Arch Gynecol Obstet 299(1):79–88

    Article  PubMed  Google Scholar 

  5. 5.

    Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43(2):227–253

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Mijatovic V, Hompes PG, Wouters MG (2003) Familial mediterranean fever and its implications for fertility and pregnancy. Eur J Obstet Gynecol Reprod Biol 108(2):171–176

    Article  PubMed  Google Scholar 

  7. 7.

    Henes M, Rall K, Igney-Oertel A, Taran F, Brucker S, Henes JC (2017) Anti-Muellerian hormone levels are not reduced in patients with adult auto-inflammatory diseases compared to healthy controls. Scand J Rheumatol 46(2):165–166. https://doi.org/10.1080/03009742.2016.1218930

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Sahin A, Karakus S, Durmaz Y, Yildiz C, Aydin H, Cengiz AK et al (2015) Evaluation of ovarian reserve with Anti-Mullerian hormone in familial mediterranean fever. Int J Rheumatol 2015:380354

    Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Ben-Chetrit E, Levy M (2003) Reproductive system in familial mediterranean fever: an overview. Ann Rheum Dis 62(10):916–919

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Yasar O, Iskender C, Kaymak O, Taflan Yaman S, Uygur D, Danisman N (2014) Retrospective evaluation of pregnancy outcomes in women with familial mediterranean fever. J Matern Fetal Neonatal Med 27(7):733–736

    Article  PubMed  Google Scholar 

  11. 11.

    Ofir D, Levy A, Wiznitzer A, Mazor M, Sheiner E (2008) Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery. Eur J Obstet Gynecol Reprod Biol 141(2):115–118

    Article  PubMed  Google Scholar 

  12. 12.

    Ben-Chetrit E, Ben-Chetrit A, Berkun Y, Ben-Chetrit E (2010) Pregnancy outcomes in women with familial mediterranean fever receiving colchicine: is amniocentesis justified? Arthritis Care Res (Hoboken) 62(2):143–148

    Article  Google Scholar 

  13. 13.

    Haimov-Kochman R, Ben-Chetrit E (1998) The effect of colchicine treatment on sperm production and function: a review. Hum Reprod 13(2):360–362

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Ben-Chetrit E, Backenroth R, Haimov-Kochman R, Pizov G (1998) Azoospermia in familial mediterranean fever patients: the role of colchicine and amyloidosis. Ann Rheum Dis 57(4):259–260

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Diav-Citrin O, Shechtman S, Schwartz V, Avgil-Tsadok M, Finkel-Pekarsky V, Wajnberg R et al (2010) Pregnancy outcome after in utero exposure to colchicine. Am J Obstet Gynecol 203(2):144.e1–144.e6

    Article  CAS  Google Scholar 

  16. 16.

    Indraratna PL, Virk S, Gurram D, Day RO (2018) Use of colchicine in pregnancy: a systematic review and meta-analysis. Rheumatology (Oxford) 57(2):382–387

    CAS  Article  Google Scholar 

  17. 17.

    Fischer-Betz R, Specker C, Schneider M (2011) Successful outcome of two pregnancies in patients with adult-onset Still’s disease treated with IL‑1 receptor antagonist (anakinra). Clin Exp Rheumatol 29(6):1021–1023

    PubMed  PubMed Central  Google Scholar 

  18. 18.

    Mont’Alverne AR, Pereira RM, Yamakami LY, Viana VS, Baracat EC, Bonfa E et al (2014) Reduced ovarian reserve in patients with Takayasu arteritis. J Rheumatol 41(10):2055–2059

    Article  PubMed  Google Scholar 

  19. 19.

    Slater CA, Liang MH, McCune JW, Christman GM, Laufer MR (1999) Preserving ovarian function in patients receiving cyclophosphamide. Lupus 8(1):3–10

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Abisror N, Mekinian A, Hachulla E, Lambert M, Morel N, Chapelon C et al (2020) Analysis of risk factors for complications and adverse obstetrical outcomes in women with Takayasu arteritis: a French retrospective study and literature review. Clin Rheumatol 39(9):2707–2713

    Article  PubMed  Google Scholar 

  21. 21.

    Assad AP, da Silva TF, Bonfa E, Pereira RM (2015) Maternal and neonatal outcomes in 89 patients with Takayasu arteritis (TA): comparison before and after the TA diagnosis. J Rheumatol 42(10):1861–1864

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    Comarmond C, Mirault T, Biard L, Nizard J, Lambert M, Wechsler B et al (2015) Takayasu arteritis and pregnancy. Arthritis Rheumatol 67(12):3262–3269

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    Comarmond C, Saadoun D, Nizard J, Cacoub P (2020) Pregnancy issues in Takayasu arteritis. Semin Arthritis Rheum 50(5):911–914

    Article  PubMed  Google Scholar 

  24. 24.

    David LS, Beck MM, Kumar M, Rajan SJ, Danda D, Vijayaselvi R (2020) Obstetric and perinatal outcomes in pregnant women with Takayasu’s arteritis: single centre experience over five years. J Turk Ger Gynecol Assoc 21(1):15–23

    Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Schmalzing M, Nau LF, Gernert M, Froehlich M, Schwaneck EC, Pecher AC et al (2020) Sexual function in German women with systemic sclerosis compared to women with systemic lupus erythematosus and evaluation of a screening test. Clin Exp Rheumatol 38(125(3)):59–64

    PubMed  PubMed Central  Google Scholar 

  26. 26.

    Tanaka H, Tanaka K, Kamiya C, Iwanaga N, Yoshimatsu J (2014) Analysis of pregnancies in women with Takayasu arteritis: complication of Takayasu arteritis involving obstetric or cardiovascular events. J Obstet Gynaecol Res 40(9):2031–2036

    Article  PubMed  Google Scholar 

  27. 27.

    Gatto M, Iaccarino L, Canova M, Zen M, Nalotto L, Ramonda R et al (2012) Pregnancy and vasculitis: a systematic review of the literature. Autoimmun Rev 11(6-7):A447–59

    Article  PubMed  Google Scholar 

  28. 28.

    Jutiviboonsuk A, Salang L, Eamudomkarn N, Mahakkanukrauh A, Suwannaroj S, Foocharoen C (2021) Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis. Clin Rheumatol 40(6):2267–2275. https://doi.org/10.1007/s10067-020-05522-5

    Article  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Mutoh T, Shirai T, Fujii H, Ishii T, Harigae H (2020) Insufficient use of corticosteroids without immunosuppressants results in higher relapse rates in Takayasu arteritis. J Rheumatol 47(2):255–263

    CAS  Article  PubMed  Google Scholar 

  30. 30.

    Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C et al (2017) Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 377(7):613–622

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  31. 31.

    Veltri NL, Hladunewich M, Bhasin A, Garland J, Thomson B (2018) De novo antineutrophil cytoplasmic antibody-associated vasculitis in pregnancy: a systematic review on maternal, pregnancy and fetal outcomes. Clin Kidney J 11(5):659–666

    Article  PubMed  PubMed Central  Google Scholar 

  32. 32.

    Singh P, Dhooria A, Rathi M, Agarwal R, Sharma K, Dhir V et al (2018) Successful treatment outcomes in pregnant patients with ANCA-associated vasculitides: a systematic review of literature. Int J Rheum Dis 21(9):1734–1740

    Article  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Tuin J, Sanders JS, de Joode AA, Stegeman CA (2012) Pregnancy in women diagnosed with antineutrophil cytoplasmic antibody-associated vasculitis: outcome for the mother and the child. Arthritis Care Res (Hoboken) 64(4):539–545

    CAS  Article  Google Scholar 

  34. 34.

    Bansal PJ, Tobin MC (2004) Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 93(4):398–401

    Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    sahIn A, Karakus S, Durmaz Y, Yildiz C, Aydin H, CengIz AK (2017) Ovarian reserve is preserved in Behcet’s disease. Int J Rheum Dis 20(12):2070–2076

    CAS  Article  Google Scholar 

  36. 36.

    Mont’Alverne AR, Yamakami LY, Goncalves CR, Baracat EC, Bonfa E, Silva CA (2015) Diminished ovarian reserve in Behcet’s disease patients. Clin Rheumatol 34(1):179–183

    Article  Google Scholar 

  37. 37.

    Henes M, Froeschlin J, Taran FA, Brucker S, Rall KK, Xenitidis T et al (2015) Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Behcet’s disease and spondyloarthritis on Anti-Mullerian hormone levels. Rheumatology (Oxford) 54(9):1709–1712

    CAS  Article  Google Scholar 

  38. 38.

    Merlino L, Del Prete F, Lobozzo B, Priori R, Piccioni MG (2020) Behcet’s disease and pregnancy: a systematic review. Minerva Ginecol 72(5):332–338

    Google Scholar 

  39. 39.

    Wu YT, Zhou LX, Yao M, Ni J, Zhu YC, Cui LY et al (2020) Clinical features of CVT in women and effect on subsequent pregnancy: a follow-up study in a Chinese national comprehensive hospital. J Stroke Cerebrovasc Dis 29(11):105274

    Article  Google Scholar 

  40. 40.

    Prieto-Pena D, Calderon-Goercke M, Adan A, Chamorro-Lopez L, Maiz-Alonso O, De Dios-Jimenez Aberasturi JR et al (2021) Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnancy. Clin Exp Rheumatol 39(1):105–114

    PubMed  PubMed Central  Google Scholar 

  41. 41.

    Gutierrez G, Dagnino R, Mintz G (1984) Polymyositis/dermatomyositis and pregnancy. Arthritis Rheum 27(3):291–294

    CAS  Article  PubMed  Google Scholar 

  42. 42.

    Vancsa A, Ponyi A, Constantin T, Zeher M, Danko K (2007) Pregnancy outcome in idiopathic inflammatory myopathy. Rheumatol Int 27(5):435–439

    CAS  Article  PubMed  Google Scholar 

  43. 43.

    Zhong Z, Lin F, Yang J, Zhang F, Zeng X, You X (2017) Pregnancy in polymyositis or dermatomyositis: retrospective results from a tertiary centre in China. Rheumatology (Oxford) 56(8):1272–1275

    Article  Google Scholar 

  44. 44.

    Gupta L, Zanwar A, Ahmed S, Aggarwal A (2020) Outcomes of pregnancy in women with inflammatory myositis: a cohort study from India. J Clin Rheumatol 26(5):165–168

    Article  PubMed  Google Scholar 

  45. 45.

    Silva CA, Sultan SM, Isenberg DA (2003) Pregnancy outcome in adult-onset idiopathic inflammatory myopathy. Rheumatology (Oxford) 42(10):1168–1172

    CAS  Article  Google Scholar 

  46. 46.

    Chen JS, Roberts CL, Simpson JM, March LM (2015) Pregnancy outcomes in women with rare autoimmune diseases. Arthritis Rheumatol 67(12):3314–3323

    Article  PubMed  Google Scholar 

  47. 47.

    El Hasbani G, Viola M, Sciascia S, Taher AT, Uthman I (2021) Antiphospholipid antibodies in inflammatory and autoimmune rheumatic and musculoskeletal diseases beyond lupus: a systematic review of the available evidence. Rheumatol Ther 8(1):81–94

    Article  PubMed  PubMed Central  Google Scholar 

  48. 48.

    Chung MP, Kolstad KD, Dontsi M, Postlethwaite D, Manwani P, Zhao H et al (2020) Increased rates of obstetric complications prior to systemic sclerosis diagnosis. Arthritis Care Res (Hoboken). https://doi.org/10.1002/acr.24533

    Article  Google Scholar 

  49. 49.

    Anjum H, Surani S (2021) Pulmonary hypertension in pregnancy: a review. Medicina (Kaunas) 57(3):259. https://doi.org/10.3390/medicina57030259

    Article  Google Scholar 

  50. 50.

    Fu J, Tomlinson G, Feig DS (2021) Increased risk of major congenital malformations in early pregnancy use of angiotensin-converting-enzyme inhibitors and angiotensin-receptor-blockers: a meta-analysis. Diabetes Metab Res Rev. https://doi.org/10.1002/dmrr.3453

    Article  PubMed  PubMed Central  Google Scholar 

  51. 51.

    Ferreira R, Negrini R, Bernardo WM, Simoes R, Piato S (2019) The effects of sildenafil in maternal and fetal outcomes in pregnancy: a systematic review and meta-analysis. PLoS ONE 14(7):e219732

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  52. 52.

    Pels A, Derks J, Elvan-Taspinar A, van Drongelen J, de Boer M, Duvekot H et al (2020) Maternal sildenafil vs placebo in pregnant women with severe early-onset fetal growth restriction: a randomized clinical trial. JAMA Netw Open 3(6):e205323

    Article  PubMed  PubMed Central  Google Scholar 

  53. 53.

    Blagojevic J, AlOdhaibi KA, Aly AM, Bellando-Randone S, Lepri G, Bruni C et al (2020) Pregnancy in systemic sclerosis: results of a systematic review and metaanalysis. J Rheumatol 47(6):881–887

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Jörg Henes.

Ethics declarations

Interessenkonflikt

J. Henes gibt folgenden Interessenkonflikt an: Vortragstätigkeiten für Roche; BMS, Janssen, Actelion, ABBVIE, UCB, Novartis, SOBI, Boehringer-Ingelheim, Lilly, GSK. A.‑C. Pecher gibt folgenden Interessenkonflikt an: Vortragstätigkeiten für GSK.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

figureqr

QR-Code scannen & Beitrag online lesen

Redaktion

Rebecca Fischer-Betz, Düsseldorf

Frauke Förger, Bern

Anja Strangfeld, Berlin

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Henes, J., Pecher, AC. Neues zu seltenen rheumatologischen Erkrankungen in der Schwangerschaft. Z Rheumatol 80, 707–715 (2021). https://doi.org/10.1007/s00393-021-01074-4

Download citation

Schlüsselwörter

  • Fertilität
  • Therapieempfehlung
  • Krankheitskontrolle
  • Therapieanpassung
  • Komplikationsrisiko

Keywords

  • Fertility
  • Treatment recommendations
  • Disease control
  • Treatment adjustment
  • Complication risk